UNITEDHEALTH GROUP INC
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
UNH$405.12+1.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations
| For the Years Ended December 31, | |||
|---|---|---|---|
| (in millions, except per share data) | 2024 | 2023 | 2022 |
| Revenues: | |||
| Premiums | $308,810 | $290,827 | $257,157 |
| Products | 50,226 | 42,583 | 37,424 |
| Services | 36,040 | 34,123 | 27,551 |
| Investment and other income | 5,202 | 4,089 | 2,030 |
| Total revenues | 400,278 | 371,622 | 324,162 |
| Operating costs: | |||
| Medical costs | 264,185 | 241,894 | 210,842 |
| Operating costs | 53,013 | 54,628 | 47,782 |
| Cost of products sold | 46,694 | 38,770 | 33,703 |
| Depreciation and amortization | 4,099 | 3,972 | 3,400 |
| Total operating costs | 367,991 | 339,264 | 295,727 |
| Earnings from operations | 32,287 | 32,358 | 28,435 |
| Interest expense | (3,906) | (3,246) | (2,092) |
| Loss on sale of subsidiary and subsidiaries held for sale | (8,310) | — | — |
| Earnings before income taxes | 20,071 | 29,112 | 26,343 |
| Provision for income taxes | (4,829) | (5,968) | (5,704) |
| Net earnings | 15,242 | 23,144 | 20,639 |
| Earnings attributable to noncontrolling interests | (837) | (763) | (519) |
| Net earnings attributable to UnitedHealth Group common shareholders | $14,405 | $22,381 | $20,120 |
| Earnings per share attributable to UnitedHealth Group common shareholders: | |||
| Basic | $15.64 | $24.12 | $21.47 |
| Diluted | $15.51 | $23.86 | $21.18 |
| Basic weighted-average number of common shares outstanding | 921 | 928 | 937 |
| Dilutive effect of common share equivalents | 8 | 10 | 13 |
| Diluted weighted-average number of common shares outstanding | 929 | 938 | 950 |
| Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents | 6 | 6 | 3 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.